Boosting the Effectiveness of Approved Neuroblastoma Drugs (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

Boosting the Effectiveness of Approved Neuroblastoma Drugs (1 of 1)

Caption

Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. This material relates to a paper that appeared in the 16 May, issue of Science Translational Medicine, published by AAAS. The paper, by T.L. Lochmann at Virginia Commonwealth University Philips Institute in Richmond, VA; and colleagues was titled, "Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma."

Credit

Ynes Bouck, www.ynesbouck.com

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.